A CRISPR screen identifies genes controlling Etv2 threshold expression in murine hemangiogenic fate commitment.
Haiyong ZhaoKyunghee ChoiPublished in: Nature communications (2017)
The ETS transcription factor Etv2 is necessary and sufficient for the generation of hematopoietic and endothelial cells. However, upstream regulators of Etv2 in hemangiogenesis, generation of hematopoietic and endothelial cells, have not been clearly addressed. Here we track the developmental route of hemangiogenic progenitors from mouse embryonic stem cells, perform genome-wide CRISPR screening, and transcriptome analysis of en route cell populations by utilizing Brachyury, Etv2, or Scl reporter embryonic stem cell lines to further understand the mechanisms that control hemangiogenesis. We identify the forkhead transcription factor Foxh1, in part through Eomes, to be critical for the formation of FLK1+ mesoderm, from which the hemangiogenic fate is specified. Importantly, hemangiogenic fate is specified not simply by the onset of Etv2 expression, but by a threshold-dependent mechanism, in which VEGF-FLK1 signaling plays an instructive role by promoting Etv2 threshold expression. These studies reveal comprehensive cellular and molecular pathways governing the hemangiogenic cell lineage development.How haematopoietic and endothelial cell lineages are specified is unclear. Here, the authors identify the forkhead transcription factor Foxh1 as regulating FLK1+ mesoderm formation in mouse embryonic stem cells, which in turn specifies hemangiogenic fate via Etv2.
Keyphrases
- transcription factor
- genome wide
- acute lymphoblastic leukemia
- endothelial cells
- embryonic stem cells
- dna methylation
- single cell
- poor prognosis
- dna binding
- crispr cas
- copy number
- genome wide identification
- high glucose
- vascular endothelial growth factor
- genome editing
- bone marrow
- rna seq
- gene expression
- binding protein
- high throughput
- stem cells
- long non coding rna
- mesenchymal stem cells
- fluorescent probe